US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Dr. Simon Drysdale, a co-leader of the HARMONIE trial, emphasised the treatment’s impact: “The thousands of winter hospital admissions caused by RSV are highly distressing for families and ...

The flu vaccine won't give you flu. And the RSV virus only affects young kids. Most important, Johns Hopkins doctors advise, ...

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...

At the start of every week, our team talks with local experts to unpack a wide range of nationwide health, safety, and ...

7. New RSV prevention options for infants and pregnant mothers A new RSV prevention option for infants was introduced in 2023: the monoclonal antibody treatment Beyfortus (nirsevimab). This shot is ...